Publications of Michaela D. Filiou
All genres
Journal Article (38)
1.
Journal Article
Antidepressant treatment effects on hippocampal protein turnover: Molecular and spatial insights from mass spectrometry. PROTEOMICS, e2100244 (2022)
2.
Journal Article
12 (2), 244 (2022)
Multi-Omics Analysis Reveals Myelin, Presynaptic and Nicotinate Alterations in the Hippocampus of G72/G30 Transgenic Mice. JOURNAL OF PERSONALIZED MEDICINE 3.
Journal Article
11 (2), 128 (2021)
Y Behavioral and Metabolome Differences between C57BL/6 and DBA/2 Mouse Strains: Implications for Their Use as Models for Depression- and Anxiety-Like Phenotypes. METABOLITES 4.
Journal Article
42 (9), pp. 573 - 588 (2019)
Anxiety and Brain Mitochondria: A Bidirectional Crosstalk. TRENDS IN NEUROSCIENCES 5.
Journal Article
13, 833 (2019)
Unraveling the Serum Metabolomic Profile of Post-partum Depression. FRONTIERS IN NEUROSCIENCE 6.
Journal Article
27 (4), pp. 2580 - 2591 (2017)
Tau Deletion Prevents Stress-Induced Dendritic Atrophy in Prefrontal Cortex: Role of Synaptic Mitochondria. CEREBRAL CORTEX 7.
Journal Article
16 (9), pp. 990 - 999 (2017)
The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation Fog. CNS & NEUROLOGICAL DISORDERS, DRUG TARGETS 8.
Journal Article
7, e1078 (2017)
Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems. TRANSLATIONAL PSYCHIATRY 9.
Journal Article
7, 15788 (2017)
Ketamine's antidepressant effect is mediated by energy metabolism and antioxidant defense system. SCIENTIFIC REPORTS 10.
Journal Article
6, 35317 (2016)
Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans. SCIENTIFIC REPORTS 11.
Journal Article
41 (7), pp. 1751 - 1758 (2016)
Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo. NEUROPSYCHOPHARMACOLOGY 12.
Journal Article
2 (1), pp. 46 - 59 (2016)
Fluoxetine Treatment Rescues Energy Metabolism Pathway Alterations in a Posttraumatic Stress Disorder Mouse Model. Molecular neuropsychiatry 13.
Journal Article
10 (12), pp. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. Proteomics. Clinical applications 14.
Journal Article
10 (12), pp. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. SI 15.
Journal Article
9 (9-10), pp. 885 - 888 (2015)
Can proteomics-based diagnostics aid clinical psychiatry? Proteomics Clinical Applications, SI 16.
Journal Article
11 (6), pp. 1536 - 1542 (2015)
Variability assessment of N-15 metabolic labeling-based proteomics workflow in mouse plasma and brain. MOLECULAR BIOSYSTEMS 17.
Journal Article
1295, pp. 293 - 303 (2015)
Protein profiling and phosphoprotein analysis by isoelectric focusing. Methods in molecular biology (Clifton, N.J.) 18.
Journal Article
58, pp. 115 - 122 (2014)
Behavioral extremes of trait anxiety in mice are characterized by distinct metabolic profiles. JOURNAL OF PSYCHIATRIC RESEARCH 19.
Journal Article
159 (2-3), pp. 365 - 369 (2014)
Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72/G30 transgenic mouse. SCHIZOPHRENIA RESEARCH 20.
Journal Article
15 (3), pp. 201 - 212 (2014)
'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared. NEUROGENETICS